Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter ...
Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...
Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.
This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
Karnataka State Budget 2026 Date, Key Announcements Live Updates: State government commitments for expenditure, particularly ...
Get the latest Sai Life Sciences share price today on NSE & BSE. Explore Sai Life Sciences stock analysis, financial performance, market capitalization, dividend history, and future outlook for ...
Medical Device Network on MSN
FDA grants breakthrough designation to PathAI for pathology solution
The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.
Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework ...
Bioavailability data recently obtained from Phase 1 study with a stable crystal form of neflamapimod manufactured using a new ...
Day One Biopharmaceuticals stock remains a "Strong Buy." Learn more about its outlook, surging revenue, and ADC pipeline ...
While an anonymous source tied the closure to shortcomings in the FDA’s new pathway, a spokesperson for the Department of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果